DDW Deputy Editor Reece Armstrong looks at the key points of GSK’s first quarter earnings. UK pharmaceutical company GSK has reported strong financial earnings for the first quarter of 2022. The pharma giant reported total sales in Q1 of £9.8 billion, crediting much of that to the company’s biopharma offerings. In a breakdown of GSK’s […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!
